Evommune, Inc. (NYSE:EVMN) ended EVO756 eczema development after a Phase 2b miss. EVO301 has positive early data, with larger ...
A ketogenic diet cut liver fat by 67% in adults with obesity, prediabetes and fatty liver disease, according to a randomized clinical trial published Aug.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results